amiodarone and curcumin

amiodarone has been researched along with curcumin in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Babu, M; Punithavathi, D; Venkatesan, N	1
Coleman, MD; Izotov, BN; Kteniadakis, S; Papadakis, GZ; Spandidos, DA; Stancioiu, F; Tsatsakis, A	1

Reviews

1 review(s) available for amiodarone and curcumin

Article	Year
A dissection of SARS‑CoV2 with clinical implications (Review). International journal of molecular medicine, 2020, Volume: 46, Issue:2 Topics: Amiodarone; Animals; COVID-19; Curcumin; Humans; Pioglitazone; Respiratory Distress Syndrome; SARS-CoV-2; Simvastatin	2020

Other Studies

1 other study(ies) available for amiodarone and curcumin

Article	Year
Protective effects of curcumin against amiodarone-induced pulmonary fibrosis in rats. British journal of pharmacology, 2003, Volume: 139, Issue:7 Topics: Amiodarone; Animals; Bronchoalveolar Lavage Fluid; Collagen Type I; Curcumin; Dose-Response Relationship, Drug; Instillation, Drug; Intubation, Gastrointestinal; L-Lactate Dehydrogenase; Lipopolysaccharides; Lung; Macrophages, Alveolar; Male; Peroxidase; Proto-Oncogene Proteins c-jun; Pulmonary Fibrosis; Rats; Rats, Inbred F344; Superoxides; Time Factors; Trachea; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Up-Regulation	2003

Article

Year

Protective effects of curcumin against amiodarone-induced pulmonary fibrosis in rats.

British journal of pharmacology, 2003, Volume: 139, Issue:7

Topics: Amiodarone; Animals; Bronchoalveolar Lavage Fluid; Collagen Type I; Curcumin; Dose-Response Relationship, Drug; Instillation, Drug; Intubation, Gastrointestinal; L-Lactate Dehydrogenase; Lipopolysaccharides; Lung; Macrophages, Alveolar; Male; Peroxidase; Proto-Oncogene Proteins c-jun; Pulmonary Fibrosis; Rats; Rats, Inbred F344; Superoxides; Time Factors; Trachea; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Up-Regulation

2003